Search Results - "Mancini, G."

Refine Results
  1. 1

    Validation of the New Small Wheel Micromegas sectors for the phase 1 upgrade of the muon forward spectrometer of the ATLAS experiment at CERN by Mancini, G

    Published in Physica scripta (01-04-2023)
    “…Abstract The ATLAS experiment is currently upgrading the first muon station in the high-rapidity region with the New Small Wheels (NSW), based on large-size…”
    Get full text
    Journal Article
  2. 2

    Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence by Saw, Jacqueline, Humphries, Karin, Aymong, Eve, Sedlak, Tara, Prakash, Roshan, Starovoytov, Andrew, Mancini, G B John

    “…Spontaneous coronary artery dissection (SCAD) is underdiagnosed and an important cause of myocardial infarction (MI), especially in young women. Long-term…”
    Get full text
    Journal Article
  3. 3

    Angiographic appearance of spontaneous coronary artery dissection with intramural hematoma proven on intracoronary imaging by Saw, Jacqueline, Mancini, G.B. John, Humphries, Karin, Fung, Anthony, Boone, Robert, Starovoytov, Andrew, Aymong, Eve

    “…Background The pathognomonic appearance of multiple radiolucent lumen on angiography is used to diagnose spontaneous coronary artery dissection (SCAD)…”
    Get full text
    Journal Article
  4. 4

    Construction and test of the SM1 MicroMegas chambers for the upgrade of the forward muon spectrometer of the ATLAS experiment by Mancini, G.

    “…MICRO MEsh GASeous structure chambers, MicroMegas (MM (Giomataris et al., 1996 [1])), is an innovative design concept for Micro-Pattern Gaseous Detectors,…”
    Get full text
    Journal Article
  5. 5

    Contemporary Review on Spontaneous Coronary Artery Dissection by Saw, Jacqueline, MD, Mancini, G.B. John, MD, Humphries, Karin H., DSc

    “…Abstract Spontaneous coronary artery dissection (SCAD) is gaining recognition as an important cause of myocardial infarction, especially in young women. There…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance by Laufs, Ulrich, Banach, Maciej, Mancini, G B John, Gaudet, Daniel, Bloedon, LeAnne T, Sterling, Lulu Ren, Kelly, Stephanie, Stroes, Erik S G

    Published in Journal of the American Heart Association (02-04-2019)
    “…Background Inability to tolerate statins because of muscle symptoms contributes to uncontrolled cholesterol levels and insufficient cardiovascular risk…”
    Get full text
    Journal Article
  9. 9

    Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study by Ballantyne, Christie M., Banach, Maciej, Mancini, G.B. John, Lepor, Norman E., Hanselman, Jeffrey C., Zhao, Xin, Leiter, Lawrence A.

    Published in Atherosclerosis (01-10-2018)
    “…Patients with hyperlipidemia who are unable to tolerate optimal statin therapy are at increased cardiovascular risk due to ongoing elevations in low-density…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease by Sedlis, Steven P, Hartigan, Pamela M, Teo, Koon K, Maron, David J, Spertus, John A, Mancini, G.B. John, Kostuk, William, Chaitman, Bernard R, Berman, Daniel, Lorin, Jeffrey D, Dada, Marcin, Weintraub, William S, Boden, William E

    Published in The New England journal of medicine (12-11-2015)
    “…Patients in the COURAGE trial who gave permission for long-term survival tracking were followed for up to 15 years. There was no difference between the PCI and…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Recommendations for statin management in primary prevention: disparities among international risk scores by Mancini, G B John, Ryomoto, Arnold, Yeoh, Eunice, Brunham, Liam R, Hegele, Robert A

    Published in European heart journal (07-01-2024)
    “…Abstract Background and Aims Statin recommendations in primary prevention depend upon risk algorithms. Moreover, with intermediate risk, risk enhancers and…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence by Brunham, Liam R, Baker, Steven, Mammen, Andrew, Mancini, G B John, Rosenson, Robert S

    Published in Cardiovascular research (01-07-2018)
    “…Abstract Statin therapy reduces cardiovascular events in patients with, or at risk of, atherosclerotic cardiovascular disease. However, statins are…”
    Get full text
    Journal Article
  19. 19
  20. 20